These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31227874)

  • 1. Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure.
    Kamiya M; Sato N; Matsuda J; Nozaki A; Akiya M; Sato T; Okazaki H; Takahashi Y; Shimizu W
    Heart Vessels; 2020 Jan; 35(1):59-68. PubMed ID: 31227874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Worsening Renal Function in Patients With Acute Decompensated Heart Failure Treated by Low-Dose Carperitide.
    Kawase Y; Kadota K; Tada T; Hata R; Iwasaki K; Maruo T; Katoh H; Mitsudo K
    Circ J; 2016; 80(2):418-25. PubMed ID: 26667591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.
    Kamiya M; Sato N; Nozaki A; Akiya M; Okazaki H; Takahashi Y; Mizuno K; Shimizu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):282-8. PubMed ID: 25748698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study.
    Nomura F; Kurobe N; Mori Y; Hikita A; Kawai M; Suwa M; Okutani Y
    Circ J; 2008 Nov; 72(11):1777-86. PubMed ID: 18832779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic blood pressure at admission as a predictor of the response to initial carperitide therapy in patients hospitalized for acute decompensated heart failure with left ventricular systolic dysfunction.
    Kajimoto K; Sashida Y; Minami Y; Yumino D; Kawarai H; Kasanuki H
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):481-8. PubMed ID: 19937464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
    Okuhara Y; Asakura M; Azuma K; Orihara Y; Nishimura K; Ando T; Kondo H; Naito Y; Kashiwase K; Hirotani S; Ishihara M; Masuyama T
    PLoS One; 2018; 13(6):e0199263. PubMed ID: 29912952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.
    Kula AJ; Hanberg JS; Wilson FP; Brisco MA; Bellumkonda L; Jacoby D; Coca SG; Parikh CR; Tang WHW; Testani JM
    Circ Heart Fail; 2016 Jan; 9(1):e002333. PubMed ID: 26699390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF).
    Nagai T; Honda Y; Nakano H; Honda S; Iwakami N; Mizuno A; Komiyama N; Yamane T; Furukawa Y; Miyagi T; Nishihara S; Tanaka N; Adachi T; Hamasaki T; Asaumi Y; Tahara Y; Aiba T; Sugano Y; Kanzaki H; Noguchi T; Kusano K; Yasuda S; Ogawa H; Anzai T
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):551-557. PubMed ID: 29098501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.
    Suzuki S; Yoshihisa A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Abe Y; Saito T; Ohwada T; Suzuki H; Saitoh S; Kubota I; Takeishi Y;
    Int Heart J; 2015; 56(2):213-8. PubMed ID: 25740399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study.
    Hata N; Seino Y; Tsutamoto T; Hiramitsu S; Kaneko N; Yoshikawa T; Yokoyama H; Tanaka K; Mizuno K; Nejima J; Kinoshita M
    Circ J; 2008 Nov; 72(11):1787-93. PubMed ID: 18812677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A Propensity Score-Matched Analysis.
    Matsue Y; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    J Card Fail; 2015 Nov; 21(11):859-64. PubMed ID: 25999241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database.
    Nagai T; Iwakami N; Nakai M; Nishimura K; Sumita Y; Mizuno A; Tsutsui H; Ogawa H; Anzai T;
    Int J Cardiol; 2019 Apr; 280():104-109. PubMed ID: 30674432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy.
    Suwa M; Seino Y; Nomachi Y; Matsuki S; Funahashi K
    Circ J; 2005 Mar; 69(3):283-90. PubMed ID: 15731532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of a Good Diuretic Response and Administration Methods for Carperitide in Patients With Acute Heart Failure.
    Inamoto M; Kohyama N; Suzuki H; Ebato M; Kogo M
    Clin Ther; 2024 Jan; 46(1):12-19. PubMed ID: 37945501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan.
    Mizuno A; Iguchi H; Sawada Y; Hurley M; Nomura H; Hayashi K; Tokuda Y; Watanabe S; Yoshikawa A
    Int J Cardiol; 2017 Aug; 241():243-248. PubMed ID: 28476514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction.
    Kajimoto K; Shimamura K
    Int J Cardiol; 2011 Jun; 149(2):e55-e58. PubMed ID: 19395093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial.
    Suzuki S; Yoshihisa A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Abe Y; Saito T; Ohwada T; Suzuki H; Saitoh S; Kubota I; Takeishi Y
    Biomed Res Int; 2014; 2014():704289. PubMed ID: 25436213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure.
    Nogi K; Ueda T; Matsue Y; Nogi M; Ishihara S; Nakada Y; Kawakami R; Kagiyama N; Kitai T; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kida K; Okumura T; Saito Y
    ESC Heart Fail; 2022 Apr; 9(2):1061-1070. PubMed ID: 35118813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.